Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD.

Journal: Eye (London, England)

PMID: 33414525

Abstract

OBJECTIVES: To study the effect of repeated retinal thickness fluctuations during the anti-VEGF therapy maintenance phase in neovascular age-related macular degeneration (nAMD).

Authors

Usha Chakravarthy

Centre for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, UK. u.chakravarthy@qub.ac.uk.
Moshe Havilio

Notal Vision Ltd., Tel Aviv, Israel.
Annie Syntosi

Novartis Pharma AG, Basel, Switzerland.
Natasha Pillai

IQVIA, Basel, Switzerland.
Emily Wilkes

IQVIA, London, UK.
Gidi Benyamini

Notal Vision Ltd., Tel Aviv, Israel.
Catherine Best

Novartis Pharma AG, Basel, Switzerland.
Alexandros Sagkriotis

Novartis Pharma AG, Basel, Switzerland.

Keywords

Angiogenesis Inhibitors Artificial Intelligence Bevacizumab Humans Intravitreal Injections Ranibizumab Subretinal Fluid Tomography, Optical Coherence Treatment Outcome Visual Acuity Wet Macular Degeneration

External Resources

View on PubMed Access via DOI PubMed (33414525)

Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals